Nuvectis Pharma paid its 3 named executives $5.8M in total in FY2025 (Dec). CEO Ron Bentsur was paid $2.6M of that.
Pay$100 in the stock at the end of FY22 → $101
Pay of each named executive
Ron BentsurChairman & CEO
| FY2025 (Dec) | ||||||
| FY2024 (Dec) | ||||||
| FY2023 (Dec) | ||||||
| FY2022 (Dec) |
4 years
Enrique PoradosuChief Scientific & Business Officer
| FY2025 (Dec) | ||||||
| FY2024 (Dec) | ||||||
| FY2023 (Dec) | ||||||
| FY2022 (Dec) |
4 years
Shay ShemeshChief Development and Operations Officer
| FY2025 (Dec) | ||||||
| FY2024 (Dec) | ||||||
| FY2023 (Dec) | ||||||
| FY2022 (Dec) |
4 years
Pay of each named executive comes from the Summary Compensation Table of each proxy statement. Realized pay adds the value of options used and stock that vested. CEO pay of each peer comes from its own Pay versus Performance table.